Literature DB >> 32929657

Genetic variants of microRNA-146a gene: an indicator of systemic lupus erythematosus susceptibility, lupus nephritis, and disease activity.

Mona E Fouda1, Dalia M Nour El Din1, Marwa Y Mahgoub2, Amany E Elashkar3, Walid A Abdel Halim1.   

Abstract

Genetic variations of microRNA encoding genes influence various sorts of diseases by modifying the expression or activity of microRNAs. MicroRNA 146a is an epigenetic regulator of immune response through controlling the type I interferon (IFN) and nuclear factor kappa B (NF-κB) pathways. Genetic variations of microRNA 146a impact the susceptibility to systemic lupus erythematosus (SLE) and its clinical presentations. This study aimed to investigate the polymorphisms of microRNA-146a gene (rs2431697 and rs57095329) in patients with SLE and its association with disease activity. Sixty-five patients with SLE and 40 apparently healthy controls were enrolled in this study. Patients were subjected to history taking, clinical examination, and disease activity evaluation by SLEDAI score. The microRNA-146a variants were determined by allele discrimination real-time PCR method in all participants. We found a statistically significant association between rs2431697 T allele and SLE (P-value < 0.05), but there was no significant association between rs57095329 and SLE. The T/T genotype of microRNA-146a rs2431697 was associated with lupus nephritis, higher disease activity, and autoantibodies production. The microRNA-146a rs2431697 T allele could be a potential risk factor that contributes to SLE susceptibility, development of lupus nephritis, and disease activity.

Entities:  

Keywords:  Genotype; Single nucleotide polymorphism; Systemic lupus erythematosus; Type I interferon; microRNA-146a

Mesh:

Substances:

Year:  2020        PMID: 32929657     DOI: 10.1007/s11033-020-05802-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  6 in total

1.  mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations.

Authors:  Basima A El-Akhras; Yasser B M Ali; Samir A El-Masry; Iman H Bassyouni; Ibrahim H El-Sayed; Roba M Talaat
Journal:  Noncoding RNA Res       Date:  2022-05-26

2.  Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy.

Authors:  Yunxia Yu; Caixia Zhu; Nan Yu; Lijuan Yang
Journal:  Cent Eur J Immunol       Date:  2021-10-19       Impact factor: 2.085

3.  Meta-Analysis of miRNA Variants Associated with Susceptibility to Autoimmune Disease.

Authors:  Jun Zhang; Handan Tan; Qingfeng Cao; Guannan Su; Peizeng Yang
Journal:  Dis Markers       Date:  2021-10-08       Impact factor: 3.434

Review 4.  Association of Immune-Related Genetic and Epigenetic Alterations with Lupus Nephritis.

Authors:  Xiaole Mei; Hui Jin; Ming Zhao; Qianjin Lu
Journal:  Kidney Dis (Basel)       Date:  2022-06-09

5.  Association between genetic variants of microRNA-21 and microRNA-155 and systemic lupus erythematosus: A case-control study from a Chinese population.

Authors:  Rong Wang; Anji Wei; Yingjie Zhang; Guidan Xu; Xuejuan Nong; Chunhong Liu; Yonglong Zeng; Huatuo Huang; Xiaoxia Pang; Wujun Wei; Chunfang Wang; Huayi Huang
Journal:  J Clin Lab Anal       Date:  2022-06-16       Impact factor: 3.124

Review 6.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.